Case Study: The EVERY Company accelerates fermentation scale-up with Culture Biosciences

The EVERY Company scales from 40L to thousands of liters with Culture Biosciences

The EVERY Company, a food-tech company producing animal-free proteins, faced a bottleneck in its bioprocess development. Their robust strain engineering platform generated more microbial candidates than they had the internal bioreactor capacity to test. To mitigate scale-up risks using their "scale-down to scale-up" approach, they needed to run a high volume of small-scale fermentations but lacked the resources and equipment to do so efficiently in-house.

Culture Biosciences provided its high-throughput bioreactor capacity and cloud-based data platform. This solution allowed The EVERY Company to run the necessary volume of parallel fermentations on short notice, testing different bioprocess conditions and raw materials without a major capital investment. The access to Culture's data visualization tools also helped them bridge the gap between engineering and biology. This partnership alleviated their testing bottleneck, accelerated their bioprocess development, and ultimately shortened their speed to market.

The EVERY Company